Breaking News

Tweet TWEET

ICU Medical Receives Premier Healthcare Alliance Contracts for its Complete Line of Needlefree IV Connectors, Sets and

 ICU Medical Receives Premier Healthcare Alliance Contracts for its Complete
            Line of Needlefree IV Connectors, Sets and Accessories

New Six-Year Contract Marks the First Time Needlefree Connectors Are
Contracted Separately from IV Pumps and Solutions by a Major GPO, Allowing
Premier Member Hospitals Greater Freedom to Make Decisions Based on Patient
Safety

PR Newswire

SAN CLEMENTE, Calif., Aug. 22, 2013

SAN CLEMENTE, Calif., Aug. 22, 2013 /PRNewswire/ --ICU Medical, Inc. (NASDAQ:
ICUI) today announced that it has received two separate six-year group
purchasing contracts from the Premier healthcare alliance covering the
company's complete line of clinically-proven needlefree IV connectors, sets
and accessories. Effective in 2014, this is the first time that group
purchasing contracts have separated needlefree IV connectors from IV pump and
solution group purchasing contracts, allowing Premier member hospitals greater
freedom in making cost-effective clinical decisions based on what is best for
patient care and safety.

(Logo: http://photos.prnewswire.com/prnh/20120906/LA68795LOGO)

"Premier has taken a bold step in breaking out needlefree IV connectors into a
separate category, once again showing that their commitment to transforming
healthcare is ultimately focused on facilitating excellence in patient care,"
explained Richard Costello, ICU Medical, Inc. Senior Vice President of Sales.
"Premier member hospitals can now more easily make decisions about which
needlefree technology to implement in their facilities based on clinical
performance without worrying about how those decisions will impact their
supply chain spend."

The new contract also marks the first time that ICU Medical's complete line of
needlefree IV connectors—which includes the Neutron^® catheter patency device,
the MicroClave^® and MicroClave Clear neutral displacement needlefree
connectors, and the NanoClave^® low profile neutral displacement connector—has
been on a single Premier contract. ICU's needlefree connectors are unique in
that they incorporate shared design features that provide an effective
microbial barrier against bacteria transfer and enable a consistent clinical
protocol to be used throughout the hospital, yet each provides a unique set of
clinical benefits.

The Neutron catheter patency device is the first FDA 510(k)-cleared technology
shown to significantly reduce all types of reflux into a catheter and be
cleared for use on all populations, including pediatric and immunocompromised
patients. It is designed to be used on central lines and has been shown to
reduce catheter occlusions by as much as 50% in regular clinical use. The
NanoClave is specifically designed to keep neonatal and pediatric patients
safe by minimizing flush volumes while providing a safe and effective
microbial barrier, while the MicroClave line of connectors is the workhorse of
the line, designed to be the "go-to" connector in all other clinical
applications.

"Each connector in our line features ICU Medical's pioneering reversed
split-septum,straight internal fluid path technology to significantly reduce
the ingress and colonization of bacteria while providing an effective barrier
against bacteria transfer and contamination," explained Mark Jorgensen, ICU
Medical General Manager of National Accounts. "Premier's decision to provide a
separate contract for needlefree connectors acknowledges that this technology
can make a real clinical difference and empowers their members to make the
right decision based on their own patient safety and outcome improvement
initiatives."

While the needlefree connector contract also includes IV extension sets that
incorporate needlefree connectors, the complete line of ICU Medical infusion
sets and accessories is available through a second six-year Premier contract.

Contact:Tom McCall
Vice President, Chief Marketing Officer
949-366-4368
tmccall@icumed.com

About ICU Medical, Inc.:ICU Medical, Inc. develops, manufactures and sells
innovative medical devices used in vascular therapy, oncology and critical
care applications. ICU Medical's products improve patient outcomes by helping
prevent bloodstream infections and protecting healthcare workers from exposure
to infectious diseases or hazardous drugs. The company's complete product line
includes custom IV systems, closed delivery systems for hazardous drugs,
needlefree IV connectors, catheters and cardiac monitoring systems. ICU
Medical is headquartered in San Clemente, California.More information about
ICU Medical, Inc. can be found atwww.icumed.com.

SOURCE ICU Medical, Inc.

Website: http://www.icumed.com
 
Press spacebar to pause and continue. Press esc to stop.